Esperion Therapeutics, Inc. ESPR
3.18 USD 0.00 (+0.00%)
At closeJul 13, 2026, 4:00 PM EDT
3.15 -0.03 -0.94%
After hours · Jul 13, 4:00 PM ET
3.18 Day range 3.18
52-week range unavailable
- YTD
- -14.05%
- 1 year
- +211.76%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 403.13M | 332.31M | 116.33M | 75.47M | 78.45M | |
| 403.13M | 332.31M | 116.33M | 75.47M | 78.45M | |
| 129.22M | 68.60M | 43.27M | 26.97M | 14.22M | |
| 273.91M | 263.71M | 73.07M | 48.51M | 64.23M | |
| 213.64M | 209.31M | 228.63M | 228.01M | 290.96M | |
| 47.85M | 46.24M | 86.11M | 118.93M | 105.97M | |
| 165.79M | 163.07M | 142.52M | 109.08M | 184.99M | |
| 60.27M | 54.40M | -155.56M | -179.50M | -226.73M | |
| 84.60M | 59.25M | 58.98M | 56.81M | 46.35M | |
| 1.84M | 0 | 0 | 0 | 0 | |
| -22.68M | -51.74M | -209.25M | -233.66M | -269.11M | |
| -22.68M | -51.74M | -209.25M | -233.66M | -269.11M | |
| -22.68M | -51.74M | -209.25M | -233.66M | -269.11M | |
| -22.68M | -51.74M | -209.25M | -233.66M | -269.11M | |
| -0.11 | -0.28 | -2.03 | -3.52 | -9.31 | |
| -0.11 | -0.28 | -2.03 | -3.52 | -9.31 | |
| -0.11 | -0.28 | -2.03 | -3.52 | -9.31 | |
| 63.76M | 7.51M | -150.27M | -176.85M | -222.75M | |
| 63.76M | 7.51M | -150.27M | -176.85M | -222.75M | |
| 207.87M | 187.18M | 103.11M | 66.41M | 28.90M | |
| 207.87M | 187.18M | 103.11M | 66.41M | 28.90M |
